| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Corp Strategy &Develop
1 company
Laplume Joseph W is an EVP, Corp Strategy &Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Recent SEC Form 4 filings include 0 buys and 71 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 18, 2020 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 15,768 | $168.40 | $2,655,297.84 | -31.4% | |
| Mar 8, 2019 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 4,490 | $137.99 | $619,587.41 | -1.2% | |
| Mar 8, 2019 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sell | 3,102 | $138.24 | $428,808.97 | -1.0% | |
| Mar 8, 2019 | CRL Charles River Laboratories International, Inc. | EVP, Corp Strategy &Develop | Sale+OE | 5,522 | $137.61 | $759,891.71 | -0.9% |